Endocyte Inc
(ECYT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2012 | 03-2012 | 12-2011 | 09-2011 | 06-2011 | |
| Sales | 7,813 | 0 | 0 | 0 | 0 |
| Gross Profit | 7,813 | N/A | N/A | N/A | N/A |
| Operating Expenses | 12,001 | 9,511 | 10,614 | 11,639 | 10,062 |
| Operating Income | -4,188 | -9,511 | -10,423 | -11,639 | -10,062 |
| Interest Expense | 280 | 347 | 351 | 449 | 491 |
| Other Income | -966 | 88 | 20 | 18 | 33 |
| Pre-tax Income | -5,433 | -9,770 | -10,754 | -12,070 | -10,519 |
| Net Income Continuous | -5,433 | -9,770 | -10,754 | -12,070 | -10,519 |
| Net Income | $-5,433 | $-9,770 | $-10,754 | $-12,070 | $-10,519 |
| EPS Basic Total Ops | -0.15 | -0.11 | -0.26 | -0.36 | -0.35 |
| EPS Basic Continuous Ops | -0.15 | -0.27 | -0.26 | -0.36 | -0.35 |
| EPS Diluted Total Ops | -0.15 | -0.11 | -0.26 | -0.36 | -0.35 |
| EPS Diluted Continuous Ops | -0.15 | -0.27 | -0.26 | -0.36 | -0.35 |
| EBITDA(a) | $-3,947 | $-9,430 | $-10,399 | $-11,492 | $-9,918 |